Mineralys Therapeutics In... (MLYS)
9.65
0.53 (5.81%)
At close: Jan 15, 2025, 12:57 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Cash & Equivalents | 49.30M | 87.70M | 10.61M | 1.41M |
| Short-Term Investments | 187.26M | 22.41M | n/a | n/a |
| Long-Term Investments | 2.48M | n/a | n/a | n/a |
| Other Long-Term Assets | 51.00K | 4.33M | 3.00K | 20.00K |
| Receivables | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a |
| Other Current Assets | 12.54M | 2.70M | 460.00K | 57.00K |
| Total Current Assets | 249.10M | 110.11M | 11.12M | 1.47M |
| Property-Plant & Equipment | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 2.53M | 4.33M | 3.00K | 20.00K |
| Total Assets | 251.64M | 114.44M | 11.13M | 1.49M |
| Account Payables | 601.00K | 1.91M | 763.00K | 529.00K |
| Deferred Revenue | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | 4.50M |
| Other Current Liabilities | 9.88M | 6.16M | 4.29M | 54.00K |
| Total Current Liabilities | 10.48M | 8.07M | 5.05M | 5.08M |
| Long-Term Debt | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | 158.64M | 29.00M | n/a |
| Total Liabilities | 10.48M | 166.71M | 34.05M | 5.08M |
| Total Debt | n/a | n/a | n/a | 4.50M |
| Common Stock | 4.00K | 1K | 1K | 1K |
| Retained Earnings | -124.71M | -52.81M | -23.01M | -3.60M |
| Comprehensive Income | n/a | -158.64M | -0.00 | 0.00 |
| Shareholders Equity | 241.15M | -52.27M | -22.93M | -3.60M |
| Total Investments | 189.75M | 22.41M | n/a | n/a |